Filing Details

Accession Number:
0001415889-24-009330
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-28 16:30:34
Reporting Period:
2024-03-26
Accepted Time:
2024-03-28 16:30:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1936258 Newamsterdam Pharma Co N.v. NAMS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341382 N James Topper C/O Frazier Life Sciences
601 Union Street, Suite 32100
Seattle WA 98101
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2024-03-26 8,429 $21.50 3,008,429 No 4 P Indirect By Frazier Life Sciences X, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Frazier Life Sciences X, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 3,801,000 Indirect By Frazier Lifesciences Sponsor LLC
Footnotes
  1. The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  2. The shares are held directly by Frazier Lifesciences Sponsor LLC. The sole member of Frazier Lifesciences Sponsor LLC is Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.